Skip to content
Abierto

Special notice

LIFE TECHNOLOGIES, STL, 657-24-4-8544-0077 (VA-24-00057080)

36C25524Q0211

Department of Veterans Affairs, 255-Network Contract Office 15. In-Vitro Diagnostic Substance Manufacturing.

Response deadline

March 15, 2024 at 4:00 PM EDT

Closed 916 days ago. Posted March 7, 2024, first published March 7, 2024. Scheduled to archive May 14, 2024.

Description

As published on SAM.gov.

DISREGARD PREVIOUS VERSION OF THIS NOTIFICATION Revised Notification The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 15 has a requirement to provide all the necessary supplies and reagents for sequencing COVID-19 and precision oncology using the Genexus NGS and purification system for the St. Louis VA Medical Center. The facility is located at 1 Jefferson Barracks Dr. St. Louis, MO 63125-4199.

This procurement is being conducted in accordance with FAR 8.405-6; Limited Source Justification Approval and no other vendor will satisfy agency requirements. This notice of intent is not a request for competitive quotes. No solicitation documents are available and telephone requests will not be accepted.

However, any firm that believes it can meet these requirements may give written notification by email to the Contracting Specialist by 3:00 PM (CST) March 15, 2024. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirements. Information must be emailed to the Contracting Specialist, Michael Murphy Michael.murphy7@va.gov TELEPHONIC INQUIRIES WILL NOT BE ACCEPTED.

Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, NCO 15 will proceed with the sole source negotiation with Life Technologies. All work to be closely coordinated with the VA Contracting Officer (CO) and Contracting Officer s Representative (COR).

Period of Performance: The Government anticipates a base and three (3) option periods that may be exercised at the discretion of the Government. In the subject line of any email sent, identify: 36C255-24-Q-0211 Genexus Reagents .

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. March 7, 2024

    Special notice

    Due March 15, 2024 at 4:00 PM EDT. SAM.gov, notice 4344b74a46964d2fb29e08b60e750fe2

  2. March 7, 2024

    Special notice

    Due March 15, 2024 at 4:00 PM EDT. SAM.gov, notice 5cfddbac1c0e49ebadc69bfb40ff3e99

Points of contact